We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
- Authors
Ismaila, Afisi S.; Rothnie, Kieran J.; Wood, Robert P.; Banks, Victoria L.; Camidge, Lucinda J.; Czira, Alexandrosz; Compton, Chris; Sharma, Raj; Millard, Shannon N.; Massey, Olivia; Halpin, David M. G.
- Abstract
This correction notice addresses errors in a study published in Respiratory Research regarding the benefits of prompt initiation of a specific inhaler for patients with COPD in England. The errors were related to the costs associated with the treatment and impacted certain statements in the "Results," "Discussion," and "Conclusions" sections of the article. The corrected information indicates that prompt initiators had numerically lower all-cause total costs and similar COPD-related costs compared to delayed initiators. The authors apologize for the discrepancies and any inconvenience caused.
- Subjects
ENGLAND; DISEASE exacerbation; COHORT analysis; FLUTICASONE; CHRONIC obstructive pulmonary disease; RETROSPECTIVE studies
- Publication
Respiratory Research, 2024, Vol 25, Issue 1, p1
- ISSN
1465-9921
- Publication type
Article
- DOI
10.1186/s12931-024-02745-x